Skip to main navigation Skip to search Skip to main content

Therapeutic potential of ketotifen in irritable bowel syndrome (IBS) may involve changes in mast cells at sites beyond the rectum Reply

  • Guy E. Boeckxstaens
  • , Tamira Klooker

Research output: Contribution to journalComment/Letter to the editorAcademic

Original languageEnglish
Pages (from-to)423
JournalGut
Volume60
Issue number3
DOIs
Publication statusPublished - 2011

Cite this